We've found
184,457
clinical trials
Alzheimer Disease Clinical Trial
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurological Observations Clinical Trial
Additional Post Hoc Analysis and Clinical Data Collection
Status: Enrolling
Updated: 1/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Opiate Addiction Clinical Trial
Long-acting Naltrexone for Pre-release Prisoners
Status: Enrolling,
Phase
III
Updated: 2/6/2018
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Adenomyosis Clinical Trial
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling,
Phase
II
Updated: 8/16/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthroplasty, Replacement, Knee Clinical Trial
Return to Physical Activities After Total Knee Arthroplasty
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Injuries, Spinal Cord Clinical Trial
ReWalk Personal Device Postmarket Study
Status: Enrolling
Updated: 2/1/2017
Click here to add this to my saved trials
Cardiac Amyloidosis Clinical Trial
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Other Clinical Trial
T Cell Therapy of Opportunistic Cytomegalovirus Infection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Carotid Artery Disease Clinical Trial
SVS VQI TransCarotid Revascularization Surveillance Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
CardiAMP™ Heart Failure Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Is Cognitive Training Neuroprotective in Early Psychosis?
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Opioid Induced Constipation Clinical Trial
Naloxegol US PMR CV Safety.
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Malaria Clinical Trial
Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Endophthalmitis Clinical Trial
ReSure Sealant Device Exposure Registry
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Fibroadenoma Clinical Trial
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurological Observations Clinical Trial
Updated: 1/15/2018
Additional Post Hoc Analysis and Clinical Data Collection
Status: Enrolling
Updated: 1/15/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Keratolysis Clinical Trial
Updated: 12/31/1969
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Updated: 12/31/1969
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Opiate Addiction Clinical Trial
Updated: 2/6/2018
Long-acting Naltrexone for Pre-release Prisoners
Status: Enrolling,
Phase
III
Updated: 2/6/2018
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Adenomyosis Clinical Trial
Updated: 8/16/2016
Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis
Status: Enrolling,
Phase
II
Updated: 8/16/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Arthroplasty, Replacement, Knee Clinical Trial
Updated: 1/23/2018
Return to Physical Activities After Total Knee Arthroplasty
Status: Enrolling
Updated: 1/23/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Injuries, Spinal Cord Clinical Trial
Updated: 2/1/2017
ReWalk Personal Device Postmarket Study
Status: Enrolling
Updated: 2/1/2017
Click here to add this to my saved trials
Cardiac Amyloidosis Clinical Trial
Updated: 12/31/1969
The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 4/12/2017
A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
T Cell Therapy of Opportunistic Cytomegalovirus Infection
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Updated: 12/31/1969
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials
Carotid Artery Disease Clinical Trial
Updated: 12/31/1969
SVS VQI TransCarotid Revascularization Surveillance Project
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
CardiAMP™ Heart Failure Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Clinical Trial
Updated: 12/31/1969
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumonia Clinical Trial
Updated: 12/31/1969
Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Updated: 12/31/1969
Is Cognitive Training Neuroprotective in Early Psychosis?
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Opioid Induced Constipation Clinical Trial
Updated: 12/31/1969
Naloxegol US PMR CV Safety.
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Malaria Clinical Trial
Updated: 6/7/2017
Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique
Status: Enrolling
Updated: 6/7/2017
Click here to add this to my saved trials
Endophthalmitis Clinical Trial
Updated: 2/14/2017
ReSure Sealant Device Exposure Registry
Status: Enrolling
Updated: 2/14/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Fibroadenoma Clinical Trial
Updated: 12/31/1969
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Updated: 12/31/1969
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Updated: 12/31/1969
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Updated: 12/31/1969
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Updated: 12/31/1969
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
Updated: 12/31/1969
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
Updated: 12/31/1969
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
Updated: 12/31/1969
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
Updated: 12/31/1969
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
Updated: 12/31/1969
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials